Galectin-3 regulates hepatic progenitor cell expansion during liver injury

Gut

Volumn 64, Issue 2, 2015, Pages 312-321

  Hsieh, Wei Chen ^a   Mackinnon, Alison C ^a   Lu, Wei Yu ^a   Jung, Jonathan ^a   Boulter, Luke ^a   Henderson, Neil C ^b   Simpson, Kenneth J ^c   Schotanus, Baukje ^a   Wojtacha, Davina ^a   Bird, Tom G ^a   Medine, Claire N ^a   Hay, David C ^a   Sethi, Tariq ^d   Iredale, John P ^c   Forbes, Stuart J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 3; LACTOSE; LAMININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT INJURY; CELL ACTIVATION; CELL ADHESION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; HEPATIC PROGENITOR CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER CELL DAMAGE; LIVER INJURY; LIVER PARENCHYMA; MACROPHAGE; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; STEM CELL EXPANSION; UPREGULATION; WILD TYPE; ADVERSE EFFECTS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; COCULTURE; DEFICIENCY; DIET; HUMAN; INJURIES; KNOCKOUT MOUSE; LIVER; LIVER REGENERATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; STEM CELL; STEM CELL NICHE;

ANIMALS; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DIET; GALECTIN 3; HEPATOCYTES; HUMANS; LAMININ; LIVER; LIVER REGENERATION; MACROPHAGES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; STEM CELL NICHE; STEM CELLS; UP-REGULATION;

EID: 84920950457     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-306290     Document Type: Article

References (47)

1. WHO. The Global Burden of Disease 2004 update. http://www.who.int/healthinfo/global-burden-disease/2004-report-update.
2. Marshall A, Rushbrook S, Davies SE, et al. Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology 2005;128:33-42.
3. Diehl AM, Chute J. Underlying potential: cellular and molecular determinants of adult liver repair. J Clin Invest 2013;123:1858-60.
4. Dorrell C, Erker L, Schug J, et al. Prospective isolation of a bipotential clonogenic liver progenitor cell in adult mice. Genes Dev 2011;25:1193-203.
5. Clouston AD, Powell EE, Walsh MJ, et al. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 2005;41:809-18.
6. Richardson MM, Jonsson JR, Powell EE, et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology 2007;133:80-90.
7. Gouw AS, Clouston AD, Theise ND. Ductular reactions in human liver: diversity at the interface. Hepatology 2011;54:1853-63.
8. Katoonizadeh A, Nevens F, Verslype C, et al. Liver regeneration in acute severe liver impairment: a clinicopathological correlation study. Liver Int 2006;26:1225-33.
9. Lowes KN, Brennan BA, Yeoh GC, et al. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 1999;154:537-41.
10. Lorenzini S, Bird TG, Boulter L, et al. Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver. Gut 2010;59:645-54.
11. Boulter L, Govaere O, Bird TG, et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med 2012;18:572-9.
12. Terada T, Nakanuma Y. Expression of tenascin, type IV collagen and laminin during human intrahepatic bile duct development and in intrahepatic cholangiocarcinoma. Histopathology 1994;25:143-50.
13. Paku S, Schnur J, Nagy P, et al. Origin and structural evolution of the early proliferating oval cells in rat liver. Am J Pathol 2001;158:1313-23.
14. Henderson NC, Mackinnon AC, Farnworth SL, et al. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci USA 2006;103:5060-5.
15. Saravanan C, Cao Z, Head SR, et al. Detection of differentially expressed wound-healing-related glycogenes in galectin-3-deficient mice. Invest Ophthalmol Vis Sci 2009;50:5690-6.
16. Friedrichs J, Torkko JM, Helenius J, et al . Contributions of galectin-3 and -9 to epithelial cell adhesion analyzed by single cell force spectroscopy. J Biol Chem 2007;282:29375-83.
17. Friedrichs J, Manninen A, Muller DJ, et al. Galectin-3 regulates integrin alpha2beta1-mediated adhesion to collagen-I and -IV. J Biol Chem 2008;283:32264-72.
18. Lagana A, Goetz JG, Cheung P, et al. Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells. Mol Cell Biol 2006;26:3181-93.
19. Hsu DK, Yang RY, Pan Z, et al. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol 2000;156:1073-83.
20. Knight B, Akhurst B, Matthews VB, et al. Attenuated liver progenitor (oval) cell and fibrogenic responses to the choline deficient, ethionine supplemented diet in the BALB/c inbred strain of mice. J Hepatol 2007;46:134-41.
21. Ichikawa S, Mucida D, Tyznik AJ, et al . Hepatic stellate cells function as regulatory bystanders. J Immunol 2011;186:5549-55.
22. Bird TG, Lu WY, Boulter L, et al. Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling. Proc Natl Acad Sci USA 2013;110:6542-7.
23. Li WL, Su J, Yao YC, et al. Isolation and characterization of bipotent liver progenitor cells from adult mouse. Stem Cells 2006;24:322-32.
24. MacKinnon AC, Farnworth SL, Hodkinson PS, et al. Regulation of alternative macrophage activation by galectin-3. J Immunol 2008;180:2650-8.
25. Henderson NC, Mackinnon AC, Farnworth SL, et al. Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis. Am J Pathol 2008;172:288-98.
26. Volarevic V, Milovanovic M, Ljujic B, et al. Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice. Hepatology 2012;55:1954-64.
27. Dragomir AC, Sun R, Choi H, et al. Role of galectin-3 in classical and alternative macrophage activation in the liver following acetaminophen intoxication. J Immunol 2012;189:5934-41.
28. Dragomir AC, Sun R, Mishin V, et al. Role of galectin-3 in acetaminopheninduced hepatotoxicity and inflammatory mediator production. Toxicol Sci 2012;127:609-19.
29. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011;11:723-37.
30. Bird TG, Lorenzini S, Forbes SJ. Activation of stem cells in hepatic diseases. Cell Tissue Res 2008;331:283-300.
31. Radi ZA, Koza-Taylor PH, Bell RR, et al. Increased serum enzyme levels associated with kupffer cell reduction with no signs of hepatic or skeletal muscle injury. Am J Pathol 2011;179:240-7.
32. Clayton E, Forbes SJ. The isolation and in vitro expansion of hepatic Sca-1 progenitor cells. Biochem Biophys Res Commun 2009;381:549-53.
33. Williams MJ, Clouston AD, Forbes SJ. Links between hepatic fibrosis, ductular reaction and progenitor cell expansion. Gastroenterology 2013;146:349-56.
34. Cheong TC, Shin JY, Chun KH. Silencing of galectin-3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents. Cancer Sci 2010;101:94-102.
35. Kim HR, Lin HM, Biliran H, et al. Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Res 1999;59:4148-54.
36. Lin HM, Pestell RG, Raz A, et al. Galectin-3 enhances cyclin D(1) promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells. Oncogene 2002;21:8001-10.
37. Wang X, Foster M, Al-Dhalimy M, et al. The origin and liver repopulating capacity of murine oval cells. Proc Natl Acad Sci USA 2003;100(Suppl 1):11881-8.
38. Ochieng J, Warfield P, Green-Jarvis B, et al. Galectin-3 regulates the adhesive interaction between breast carcinoma cells and elastin. J Cell Biochem 1999;75:505-14.
39. Ochieng J, Leite-Browning ML, War field P. Regulation of cellular adhesion to extracellular matrix proteins by galectin-3. Biochem Biophys Res Commun 1998;246:788-91.
40. Ochieng J, Green B, Evans S, et al . Modulation of the biological functions of galectin-3 by matrix metalloproteinases. Biochim Biophys Acta 1998;1379:97-106.
41. Goetz JG, Joshi B, Lajoie P, et al. Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin-1. J Cell Biol 2008;180:1261-75.
42. Dong S, Hughes RC. Macrophage surface glycoproteins binding to galectin-3 (Mac-2-antigen). Glycoconj J 1997;14:267-74.
43. Henderson NC, Collis EA, Mackinnon AC, et al. CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation. J Biol Chem 2004;279:54731-41.
44. Fenczik CA, Sethi T, Ramos JW, et al. Complementation of dominant suppression implicates CD98 in integrin activation. Nature 1997;390:81-5.
45. Hsu DK, Chen HY, Liu FT. Galectin-3 regulates T-cell functions. Immunol Rev 2009;230:114-27.
46. Haudek KC, Spronk KJ, Voss PG, et al. Dynamics of galectin-3 in the nucleus and cytoplasm. Biochim Biophys Acta 2010;1800:181-9.
47. Thomas JA, Pope C, Wojtacha D, et al. Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology 2011;53:2003-15.